Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type
Sort descending
|
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan | |
Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
|
Education | Internal Medicine | All | |
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
Release Date:
|
Education | Hospital | All | |
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
|
Education | Vaccines | Japan | |
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
|
Education | Health Equity | China | |
|
Release Date:
|
Education | Internal Medicine | USA | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada |
| Title |
Grant Type
Sort descending
|
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis
Release Date:
|
||||
Pfizer and Global Bridges at Mayo Clinic: Treating Tobacco Dependence- Europe Program
Release Date:
|
||||
Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
Release Date:
|
||||
Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
Release Date:
|
||||
Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
Release Date:
|
||||
Pediatric Immunization Series Completion
Release Date:
|
||||
Facilitation of the Diagnosis of Rheumatoid Arthritis
Release Date:
|
||||
Pfizer and NCCN: Metastatic Breast Cancer
Release Date:
|
||||
Improving Care of Chronic Pain- Physician Groups and Health Systems
Release Date:
|
||||
Achievement of Treat-to-Target in Rheumatoid Arthritis
Release Date:
|
||||
Anticoagulation Education - NVAF or VTE
Release Date:
|
||||
Transition of Care in VTE
Release Date:
|